BioCentury | Nov 6, 2014
Distillery Therapeutics

Indication: Cancer

...et al. Cancer Res.; published online Oct. 3, 2014; doi:10.1158/0008-5472.CAN-14-1736 Contact: Heinrich Kovar, St. Anna Children's Cancer Research Institute...
BioCentury | Jan 20, 2014
Company News

Apeiron Biologics, Gen Pharmaceuticals Inc., Medison sales and marketing update

...plans to submit regulatory applications in the U.S. and EU this year. In 2011, the Children's Cancer Research Institute...
BioCentury | Oct 21, 2013
Clinical News

Ch14 regulatory update

...plans to submit regulatory applications in the U.S. and EU next year. In 2011, the Children's Cancer Research Institute...
BioCentury | Jan 21, 2013
Company News

Apeiron Biologics, Paladin sales and marketing update

...testing in Europe for high-risk neuroblastoma. The companies declined to provide details. In 2011, the Children's Cancer Research Institute...
BioCentury | Jun 27, 2011
Company News

Apeiron Biologics, Children's Cancer Research deal

...The Children's Cancer Research Institute (Vienna, Austria) and the European Neuroblastoma Research Network (SIOPEN) granted Apeiron exclusive, worldwide rights...
...Merck KGaA (Xetra:MRK, Darmstadt, Germany) (see BioCentury, Feb. 7). Apeiron Biologics AG , Vienna, Austria Children's Cancer Research Institute...
BioCentury | Jun 24, 2011
Company News

Apeiron gains rights to Phase III neuroblastoma candidate

...The Children's Cancer Research Institute (Vienna, Austria) and the European Neuroblastoma Research Network (SIOPEN) granted Apeiron Biologics AG (Vienna...
Items per page:
1 - 6 of 6
BioCentury | Nov 6, 2014
Distillery Therapeutics

Indication: Cancer

...et al. Cancer Res.; published online Oct. 3, 2014; doi:10.1158/0008-5472.CAN-14-1736 Contact: Heinrich Kovar, St. Anna Children's Cancer Research Institute...
BioCentury | Jan 20, 2014
Company News

Apeiron Biologics, Gen Pharmaceuticals Inc., Medison sales and marketing update

...plans to submit regulatory applications in the U.S. and EU this year. In 2011, the Children's Cancer Research Institute...
BioCentury | Oct 21, 2013
Clinical News

Ch14 regulatory update

...plans to submit regulatory applications in the U.S. and EU next year. In 2011, the Children's Cancer Research Institute...
BioCentury | Jan 21, 2013
Company News

Apeiron Biologics, Paladin sales and marketing update

...testing in Europe for high-risk neuroblastoma. The companies declined to provide details. In 2011, the Children's Cancer Research Institute...
BioCentury | Jun 27, 2011
Company News

Apeiron Biologics, Children's Cancer Research deal

...The Children's Cancer Research Institute (Vienna, Austria) and the European Neuroblastoma Research Network (SIOPEN) granted Apeiron exclusive, worldwide rights...
...Merck KGaA (Xetra:MRK, Darmstadt, Germany) (see BioCentury, Feb. 7). Apeiron Biologics AG , Vienna, Austria Children's Cancer Research Institute...
BioCentury | Jun 24, 2011
Company News

Apeiron gains rights to Phase III neuroblastoma candidate

...The Children's Cancer Research Institute (Vienna, Austria) and the European Neuroblastoma Research Network (SIOPEN) granted Apeiron Biologics AG (Vienna...
Items per page:
1 - 6 of 6